What does microsatellite instability (MSI) mean for Leukemia

Microsatellite Instability (MSI) and Leukemia

I appreciate your question about MSI and leukemia. Let me explain what I found when reviewing the current leukemia guidelines.

What the Guidelines Show

After reviewing the NCCN Guidelines for Patients on Acute Myeloid Leukemia (2025) and Chronic Myeloid Leukemia (2025), I need to be transparent: microsatellite instability is not discussed as a biomarker or testing consideration for leukemia patients.

This is actually important information in itself. Here's why:

Why MSI Matters in Some Cancers (But Not Typically in Leukemia)

MSI refers to changes in short, repetitive DNA sequences called microsatellites. This biomarker is very important in certain solid tumors like colorectal cancer and endometrial cancer, where it helps predict treatment response and prognosis.

However, leukemias follow a different genetic framework for diagnosis and treatment planning.

What Leukemia Doctors Actually Test For

According to the NCCN Guidelines, leukemia testing focuses on different genetic changes:

• Gene mutations like FLT3, NPM1, TP53, and others
• Chromosome changes like t(8;21), inv(16), and del(5q)
• Specific fusion genes like BCR::ABL1 (in chronic myeloid leukemia)
• Flow cytometry to identify cell markers

These biomarkers are what guide treatment decisions in leukemia, not MSI.

Questions to Ask Your Care Team

If you've heard about MSI in relation to your leukemia diagnosis:

1. "Did my genetic testing include microsatellite instability testing, and if so, what did it show?"
2. "What specific genetic mutations or chromosome changes were found in my leukemia cells?"
3. "How do these findings affect my treatment options?"
4. "Are there any hereditary cancer syndromes I should know about?" (The NCCN Guidelines note that some leukemias can be associated with inherited predisposition syndromes)

The Bottom Line

MSI is not a standard biomarker for leukemia diagnosis or treatment planning. Your oncology team will focus on the genetic and chromosomal changes that are specific to blood cancers. If MSI testing was done as part of your workup, ask your doctor specifically what it means for your individual case.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.